摘要 |
<P>PROBLEM TO BE SOLVED: To provide highly safe pharmaceuticals enabling kidney fibrosis to be prevented and treated through inhibiting kidney's VKOR (vitamin k epoxide reductase). Ž<P>SOLUTION: The pharmaceuticals, i.e. curative or preventive agents for kidney fibrosis, include a lactone derivative represented by chemical formula (II) (wherein, R<SP>1</SP>is H, halogen atom, substituted alkyl or the like; R<SP>2</SP>is H, alkyl, acyl, heterocyclic group or the like), an enlarged cyclic six-membered cyclic lactone derivative derived therefrom, and pharmacologically acceptable salts thereof. Ž<P>COPYRIGHT: (C)2010,JPO&INPIT Ž
|